Two RSV vaccines for seniors have completed phase 3 trials and demonstrated beneficial results. The public still awaits FDA decisions on potential approvals for both.
Jason Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS
Advertisement
Articles by Jason Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS
Advertisement
Latest Updated Articles
The Wait for RSV Vaccines ContinuesApril 26th 2023
Advertisement
Advertisement
Trending on Drug Topics
1
Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand
2
Individualized Approach Helps When Intensifying GLP-1 Therapy in T2D
3
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
4
Meta-Analysis Identifies 5 Risk Factors for Post-COVID-19 Condition
5